Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

2018307 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 20, Issue 1, pp. 120-133

Field-Weighted Citation Impact: 24.98